Startups
GenScript ProBio is proactively providing end-to-end CDMO service from drug discovery to commerciali
Overview
Location
United States, New Jersey, Piscataway Township
Employees
1001-5000
Phone
+1 732-885-9188
Founded date
2002
Mentions in press and media 23
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 13, 2023 | GenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS | SEOUL, South Korea, Oct. 13, 2023 /PRNewswire/ -- Recently, ABL Bio, a partner of GenScript ProBio, announced the Ministry of Food and Drug Safety (MFDS) cleared of its clinical trial application for innovative bispecific antibody program (... |
| Mar 7, 2023 | GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS | NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, announced MFDS (Ministry of Food and Drug Safety) clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T prog... |
| Feb 22, 2023 | GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate | PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development a... |
| Feb 8, 2023 | A Joint Collaboration Between Bio Immunitas and GenScript ProBio Leads to the Development and Fast Track Manufacturing of A Novel Therapeutic Platform | NANJING, China, Feb. 8, 2023 /PRNewswire/ -- GenScript ProBio, a leading Biologics CDMO to the bio-pharmaceutical market, and Bio Immunitas, a UK pharmaceutical company with a novel, safe and efficacious human Recombinant Protein Platform (... |
| Dec 5, 2022 | Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp | NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris&... |
| Nov 29, 2022 | A bispecific antibody molecule jointly developed by Buchang Pharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, received IND clearance from NMPA for clinical trial | NANJING, China, Nov. 29, 2022 /PRNewswire/ -- Buchang Biopharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, recently received IND approval of BC008-1A from China NMPA for Phase 1 clinical trial. BC008-1A (NMPAIND number:... |
| Oct 18, 2022 | GenScript ProBio Signs MOU to Form Strategic Partnership with GeneCraft To Development and Production of New AAV gene therapies | SEOUL, South Korea, Oct. 18, 2022 /PRNewswire/ -- On the Oct 17, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and GeneCraft (Suk Chul Bae, CEO), a global research team led by Professor Suk Chul Bae of lung cancer mechanis... |
| Sep 15, 2022 | GenScript Receives Best Cell & Gene Therapy Supplier Award: Gene Editing and GenScript ProBio Receives Best Biologics CMO Awards: Upstream Processing & Analytical Services | SINGAPORE, Sept. 15, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) and GenScriptProBio (a global one-stop CDMO from GenScript Group) receive 3 awards: Best Cell & Gene Therapy Supplier A... |
| Aug 23, 2022 | GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program | NANJING, China, Aug. 23, 2022 /PRNewswire/ -- Recently, Selecxine, a partner of GenScript ProBio, announces FDA clearance of its IND application for innovative antibody drug program (SLC-3010). GenScript ProBio was responsible for the CMC d... |
Show more
Reviews 0
FAQ about GenScript ProBio
When was GenScript ProBio founded?
GenScript ProBio was founded in 2002.
What has the press written about GenScript ProBio?
Parsers VC has collected 23 articles mentioning GenScript ProBio, among them “GenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS” (Oct 13, 2023) and “GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS” (Mar 7, 2023).
Is GenScript ProBio still active?
Yes, GenScript ProBio is active; its latest activity on Parsers VC dates from Aug 17, 2025.